Reproducible Drug Combination Assay
Corresponding Organization : Austral University of Chile
Other organizations : University of Chile, Universidad de La Frontera
Variable analysis
- Indomethacin
- GW9662
- Methoctramine
- Cell viability
- Protein expression (for immunoblotting)
- Concentration of DMSO in the culture medium (kept at a maximum of 0.5% and did not influence cell viability)
- Duration of drug exposure (24 h for immunoblotting, 72 h for cell viability and combination studies)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!